my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Evotec AG announced a research collaboration with Harvard University aimed at discovering and developing novel anti-bacterial agents based on a highly validated target family involved in bacterial cell wall biosynthesis. Under the Agreement, researchers at Harvard and Evotec will collaborat ... more
Naturally occurring "keystone" molecules that have powerful behavioral effects on diverse organisms often play large but unrecognized roles in structuring ecosystems, according to a theory proposed in the June issue of BioScience. The authors of the theory, Ryan P. Ferrer of Seattle Pacific ... more
A recent study by a team of researchers at the University of Nevada, Las Vegas found that risky sexual behavior can be predicted by cultural, socioeconomic and individual mores in conjunction with how one views themselves. Katherine Hertlein of the University of Nevada, Las Vegas will prese ... more
Despite previous studies touting its benefit in moderating gout risk, new research reveals that vitamin C, also known ascorbic acid, does not reduce uric acid (urate) levels to a clinically significant degree in patients with established gout. Vitamin C supplementation, alone or in combinat ... more
Photographers know the problem all too well: with the naked eye, you can see which branch a bird is sitting on, but spotting the bird in the blur of branches through the telephoto lens for high-magnification images requires considerable skill. It is a similar story for researchers who are l ... more
In the first six months of financial year 2012/2013 medical technology company Carl Zeiss Meditec increased its revenue by 2.6% compared with the same period of the previous year, to € 443 million. Earnings before interest and tax improved to € 64.1 million (previous year: € 61.1 million); ... more
OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3rd 2013 calls for OPXBIO to use its proprietary EDGE™ (Efficiency Dir ... more
Merck Serono announced that based on its recent analysis of the human growth hormones (HGH) market, Frost & Sullivan recognises Merck Serono with the 2013 Europe Product Differentiation Excellence Award. “Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool. ... more
SYGNIS Pharma AG announced its financial results according to IFRS for the first quarter of 2013, ending 31 March 2013. In the first quarter of 2013, revenues amounted to €0.1 million; operating expenses amounted to €1.3 million. Operating expenses include sales, general & administrative co ... more
How cells regulate their own function by "accelerating and braking" is important basic knowledge when new intelligent medicines are being developed, or when plant cells are tweaked to produce more bioenergy. In a study published by Nature Communications, researchers at Uppsala and Umeå univ ... more
Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik ... more
Scientists in Spain have developed a disposable magnetic bead-based immunosensor to detect the hormone leptin. Leptin helps regulate food intake and is thought to play a role in obesity. This new sensor is very sensitive with a lower limit of detection than current immunoassays. The sensor ... more
A 2D-HPLC-UV-ICP-MS system has been developed by scientists in China for the separation and recognition of mercury-binding proteins in human plasma. Environmental mercury can come from both natural and anthropogenic sources and then be biomagnified through the food chain. Exposure can come ... more
For three days, high-quality laboratory equipment and the latest analysis devices were the focus of the third analytica Vietnam in Ho Chi Minh City. 114 exhibitors from ten countries presented their exhibits to more than 3,400 trade visitors. The content in the program of related events, wh ... more
Analytik Jena AG (AJA) expects sales for the current financial year 2012/2013 to exceed EUR 100.0 m for the first time in the Company's history. This was announced today by the manufacturer of analytical instrumentation, life science instruments and optoelectronics in the run-up to its Annu ... more
Researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) have achieved a major advance in understanding how genetic information is transcribed from DNA to RNA by providing the first step-by-step look at the biomolecular machinery that reads ... more
Two USC scientists have developed an algorithm that could help make DNA sequencing affordable enough for clinics – and could be useful to researchers of all stripes.Andrew Smith, a computational biologist at the USC Dornsife College of Letters, Arts and Sciences, developed the algorithm alo ... more
UK scientists have designed a high throughput method to determine the phenotypes of the different Escherichia coli strains that cause urinary tract infections. The method couples bacterial growth requirements to Fourier transform infrared spectroscopy. The majority of urinary tract infectio ... more
Programmed cell death, or apoptosis, occurs tens of millions of times every day in every human body. Researchers in South Korea have devised an easy method to detect apoptotic cells by fluorescence, as they report in Chemistry—An Asian Journal. Their method makes it easier to detect imprope ... more
The Fraunhofer Institute for Photonic Microsystems IPMS will be presenting an extremely miniaturized near-infrared spectrometerThis device enables analysis of gaseous, liquid and solid materials immediately on site instead of taking samples for lab analysis. The optical bench is smaller tha ... more
Evotec AG announced a research collaboration with Harvard University aimed at discovering and developing novel anti-bacterial agents based on a highly validated target family involved in bacterial cell wall biosynthesis. Under the Agreement, researchers at Harvard and Evotec will collaborat ... more
Photographers know the problem all too well: with the naked eye, you can see which branch a bird is sitting on, but spotting the bird in the blur of branches through the telephoto lens for high-magnification images requires considerable skill. It is a similar story for researchers who are l ... more
In the first six months of financial year 2012/2013 medical technology company Carl Zeiss Meditec increased its revenue by 2.6% compared with the same period of the previous year, to € 443 million. Earnings before interest and tax improved to € 64.1 million (previous year: € 61.1 million); ... more
The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and wil ... more
During the first six months of fiscal year 2012/13 the business trend in the ZEISS Group was marked by the difficult conditions experienced in some markets. Nevertheless, the Group concluded the first half of the year (ended 31 March) with revenue totaling EUR 1.978 billion (first six month ... more
Evogene Ltd. (EVGN) announced its financial results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 grew to $4.6 million, compared to $4.2 million for the same period in 2012. Evogene’s current revenues consist primarily of research and licensing revenues ... more
From microscopes to MRI scanners, imaging technology is growing ever more vital in the world's hospitals, whether for the diagnosis of illness or for research into new cures. Imaging technology requires dyes or contrast agents of some sort. Current contrast agents and dyes are expensive, di ... more
Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik ... more
The trend towards automated high content assays, particularly for systems biology and drug discovery, has stimulated the development of automated fluorescence microscopy systems to image sample arrays. Today’s commercially available high content analysis (HCA) instruments predominantly empl ... more
Researchers in South Korea have developed a three-dimensional liver model that can recreate cell signalling within the organ. The liver on a chip could cut tests on animals by providing an accurate artificial model of how the organ responds to new drugs. The team, led by SangHoon Lee, at Ko ... more
Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik ... more
Quinten announced the identification of two discriminating biological marker candidates which are indicative of a favorable response to treatment in women suffering from triple-negative breast cancer (TNBC). In the sub-group with both markers in combination, 86 per cent of women responded t ... more
Hologic, Inc.announced that a new study published in Radiology, found that the addition of three dimensional mammography screening technology to a 2D breast screening exam significantly increased cancer detection while reducing the number of false positives. The study, "Comparison of Digita ... more
SIRS-Lab requested the opening of insolvency proceedings. The company, founded ten years ago, develops molecular diagnostic technologies for life-threatening infections as sepsis, also known as blood poisoning. Sepsis claims 250.000 victims per year in the USA alone. Therefore SIRS-Lab has ... more
Lab21 Limited announced the sale of its laboratory operations based in South Carolina to Reedy Acquisitions Corp, an entity formed by the existing local management and South Carolina based investors. In addition to an immediate cash benefit for Lab21 Ltd, the sale will remove a loss-making ... more
A software tool called PredictAD developed by VTT Technical Research Centre of Finland promises to enable earlier diagnosis of the disease on the basis of patient measurements and large databases. Alzheimer’s disease currently takes on average 20 months to diagnose in Europe. VTT has shown ... more
All patients with Alzheimer's disease (AD) lose brain cells, which leads to a shrinking, or atrophy, of the brain. But the pattern of gray matter loss is significantly different in men and women, according to a study presented at the annual meeting of the Radiological Society of North Ameri ... more
An estimated 220 million people become infected with malaria each year. The disease is often lethal – particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is import ... more
Thermo Fisher Scientific Inc. announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company’s global manufacturing footprint and establishes local production capabilities to meet increa ... more
Skuldtech, a genomic and pharmacogenomic company specialized in developing diagnostic tests, announced it has successfully used its technological platform to identify new biomarkers during a phase III clinical trial. This discovery made it possible to file a marketing authorization applicat ... more
During the first six months of fiscal year 2012/13 the business trend in the ZEISS Group was marked by the difficult conditions experienced in some markets. Nevertheless, the Group concluded the first half of the year (ended 31 March) with revenue totaling EUR 1.978 billion (first six month ... more
Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik ... more
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved funding for ten additional core facilities to make existing research instrumentation more easily and efficiently accessible to researchers. This decision was made by the DFG's Joint Committee. The projects wi ... more
For three days, high-quality laboratory equipment and the latest analysis devices were the focus of the third analytica Vietnam in Ho Chi Minh City. 114 exhibitors from ten countries presented their exhibits to more than 3,400 trade visitors. The content in the program of related events, wh ... more
Analytik Jena AG (AJA) expects sales for the current financial year 2012/2013 to exceed EUR 100.0 m for the first time in the Company's history. This was announced today by the manufacturer of analytical instrumentation, life science instruments and optoelectronics in the run-up to its Annu ... more
Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as ... more
Copley Scientific’s Swiss office is currently celebrating its tenth highly successful year of providing expert sales and technical support to customers across Europe. Based in Therwil, the office delivers high quality, local language services to France, Germany, Italy, Austria and Switzerla ... more
The Fraunhofer Institute for Biomedical Engineering IBMT is working on future lab technology. The project is funded by the state government of Germany´s Saarland and unites local and national partners from industry and craftsmanship. Built and financed in the framework of the project »Labor ... more
His invention revolutionised modern chemistry: at the end of the 19th century, Otto Schott, founder of modern glass technology and what is now SCHOTT AG, invented a laboratory glass made from borosilicate glass, a completely new type of technical glass. It was the first special glass with h ... more
Qlucore has announced an agency agreement with Novo Newton Scientific Ltd. Novo Newton will assist in marketing Qlucore's Omics Explorer software in Ireland, Spain, Italy and South Africa. Recently Qlucore has also signed a distribution agreement in Japan, and raised investment finance for ... more
Evotec AG announced a research collaboration with Harvard University aimed at discovering and developing novel anti-bacterial agents based on a highly validated target family involved in bacterial cell wall biosynthesis. Under the Agreement, researchers at Harvard and Evotec will collaborat ... more
SYGNIS Pharma AG announced its financial results according to IFRS for the first quarter of 2013, ending 31 March 2013. In the first quarter of 2013, revenues amounted to €0.1 million; operating expenses amounted to €1.3 million. Operating expenses include sales, general & administrative co ... more
Enantioselectivity has been recognized in the fields of life science, pharmacology, modern medicine, and chemistry. The increasing release of chiral persistent organic pollutants (POPs) into the environment in recent decades has led to an increase in scientific research into their environme ... more
The trend towards automated high content assays, particularly for systems biology and drug discovery, has stimulated the development of automated fluorescence microscopy systems to image sample arrays. Today’s commercially available high content analysis (HCA) instruments predominantly empl ... more
The first details of the planned reorganisation of the European Medicines Agency (EMA) have been announced. Rooted firmly in the Agency’s overall public and animal health mission, the changes reflect a renewed focus on three key elements: how to better support the scientific work of the EMA ... more
Scientists in India report the functionalisation of TiO2 nanoparticles with two different biomolecules – tris-(nitrilo tris-acetic acid) and biotin. The biocompatible nanoparticles is non-cytotoxic and can deliver multiple biomolecules into the cell. In the future the nanoparticles could ac ... more
Researchers in South Korea have developed a three-dimensional liver model that can recreate cell signalling within the organ. The liver on a chip could cut tests on animals by providing an accurate artificial model of how the organ responds to new drugs. The team, led by SangHoon Lee, at Ko ... more
Scientists from Singapore report the development of a nanoparticle-based drug delivery vehicle that is capable of releasing drugs upon external stimuli. They have made amphiphilic polymer coated gold nanoparticles which self-assemble into vesicles. The hydrophobic polymer on the gold nanopa ... more
The European Medicines Agency (EMA) has been ordered by the General Court of the European Union not to provide documents as part of two access-to-documents requests until a final ruling is given by the Court. These interim rulings were made as part of court cases brought by two pharmaceutic ... more
The new feature of the antidepressant drugs of the 1990s was that they had milder side-effects than their predecessors. Combined with aggressive marketing, this meant that annual sales in Sweden increased from just under EUR 18 million to over EUR 100 million in the space of just a few year ... more
A recent study by a team of researchers at the University of Nevada, Las Vegas found that risky sexual behavior can be predicted by cultural, socioeconomic and individual mores in conjunction with how one views themselves. Katherine Hertlein of the University of Nevada, Las Vegas will prese ... more
Despite previous studies touting its benefit in moderating gout risk, new research reveals that vitamin C, also known ascorbic acid, does not reduce uric acid (urate) levels to a clinically significant degree in patients with established gout. Vitamin C supplementation, alone or in combinat ... more
How cells regulate their own function by "accelerating and braking" is important basic knowledge when new intelligent medicines are being developed, or when plant cells are tweaked to produce more bioenergy. In a study published by Nature Communications, researchers at Uppsala and Umeå univ ... more
In young people, blood vessels appear to be able to compensate for the effects of obesity. But after middle age, this adaptability is lost, and arteries become progressively stiffer as body fat rises – potentially increasing the risk of dying from cardiovascular disease. The researchers sug ... more
Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers at Johns Hopkins University in Baltimore. "Although allergic sensitiz ... more
Having trouble falling or staying asleep? According to a new study led by a team of researchers at the Johns Hopkins Bloomberg School of Public Health, insomnia may be an important indicator of future hospitalization among middle-aged and older adults. They examined the association between ... more
Enantioselectivity has been recognized in the fields of life science, pharmacology, modern medicine, and chemistry. The increasing release of chiral persistent organic pollutants (POPs) into the environment in recent decades has led to an increase in scientific research into their environme ... more
The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and wil ... more
Regular marijuana use is associated with favorable indices related to diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and were less likely to be insulin resistant, even after excluding patients with a diagnosis of diabetes ... more
Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life ... more
Serotonin mediates exercise-induced generation of new neurons
Chemistry breakthrough sheds new light on illness and health
Tactics of new Middle East virus suggest treating by altering lung cells' re ...
New stats: Plastic surgery trend has women armed for spring and summer
X-ray analysis could boost legumes, thus reducing fertilizer pollution
Calcium in the nucleus renders neurons chronically sensitive to pain
Margaret Gourlay wins Top 10 Clinical Research Achievement Award from Clinic ...
New findings on the brain’s immune cells during Alzheimer’s disease progression
Launch of semi-synthetic artemisinin a milestone for malaria
Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik ... more
For three days, high-quality laboratory equipment and the latest analysis devices were the focus of the third analytica Vietnam in Ho Chi Minh City. 114 exhibitors from ten countries presented their exhibits to more than 3,400 trade visitors. The content in the program of related events, wh ... more
Promega and BASF have jointly developed an alternative method to animal studies that can reliably detect the allergenic potential of substances. Using a newly developed cell line, the reaction of skin cells to allergenic substances can now be demonstrated in the test tube. Allergic skin rea ... more
In the first six months of financial year 2012/2013 medical technology company Carl Zeiss Meditec increased its revenue by 2.6% compared with the same period of the previous year, to € 443 million. Earnings before interest and tax improved to € 64.1 million (previous year: € 61.1 million); ... more
OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3rd 2013 calls for OPXBIO to use its proprietary EDGE™ (Efficiency Dir ... more
Merck Serono announced that based on its recent analysis of the human growth hormones (HGH) market, Frost & Sullivan recognises Merck Serono with the 2013 Europe Product Differentiation Excellence Award. “Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool. ... more
BASF globally increases the price for vitamin B2-products for human and animal nutrition by 10% with immediate effect respectively according to existing contracts terms at the earliest possible date. more
Effective immediately, Evonik Industries is increasing the prices for the products L-Ornithine-L-Aspartate, L-Proline, L-Lysine salts, L-Methionine, L-Arginine-L-Aspartate, Glycine and all other cGMP-grade amino acids. The increase amounts to 10 – 20 percents and applies globally to all new ... more
Effective September 1, 2011, BASF will increase the sales prices globally for all pharmaceutical excipients and generic active pharmaceutical ingredients by 10%. This price increase affects the entire excipients portfolio including all binders, disintegrants, coatings, solubilizers, and sol ... more
Evotec AG announced a research collaboration with Harvard University aimed at discovering and developing novel anti-bacterial agents based on a highly validated target family involved in bacterial cell wall biosynthesis. Under the Agreement, researchers at Harvard and Evotec will collaborat ... more
Naturally occurring "keystone" molecules that have powerful behavioral effects on diverse organisms often play large but unrecognized roles in structuring ecosystems, according to a theory proposed in the June issue of BioScience. The authors of the theory, Ryan P. Ferrer of Seattle Pacific ... more
A recent study by a team of researchers at the University of Nevada, Las Vegas found that risky sexual behavior can be predicted by cultural, socioeconomic and individual mores in conjunction with how one views themselves. Katherine Hertlein of the University of Nevada, Las Vegas will prese ... more
Definiens announced the appointment of renowned surgical and anatomical pathologist Dr. Ralf Huss as Chief Medical Officer (CMO). Professor Huss brings significant expertise in pathology and will play a key role in expanding Definiens’ leading position in image and data analysis for Digital ... more
AMRI announced that it has promoted Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia. Dr. Yura will report directly to Thomas E. D'Ambra, Ph.D., Chairman, President and CEO. Dr. Yura joined AMRI in January 2011 and most recently served as Senior Director of ... more
Outgoing president Harriet Wallberg-Henriksson will pass the baton to Anders Hamsten making him the 21st president of Karolinska Institutet. The Swedish government appoints the president of Karolinska Institutet, and Anders Hamsten will lead Sweden’s medical university until 31 December 201 ... more
In the first six months of financial year 2012/2013 medical technology company Carl Zeiss Meditec increased its revenue by 2.6% compared with the same period of the previous year, to € 443 million. Earnings before interest and tax improved to € 64.1 million (previous year: € 61.1 million); ... more
SYGNIS Pharma AG announced its financial results according to IFRS for the first quarter of 2013, ending 31 March 2013. In the first quarter of 2013, revenues amounted to €0.1 million; operating expenses amounted to €1.3 million. Operating expenses include sales, general & administrative co ... more
During the first six months of fiscal year 2012/13 the business trend in the ZEISS Group was marked by the difficult conditions experienced in some markets. Nevertheless, the Group concluded the first half of the year (ended 31 March) with revenue totaling EUR 1.978 billion (first six month ... more
OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3rd 2013 calls for OPXBIO to use its proprietary EDGE™ (Efficiency Dir ... more
Oxford BioMedica plc announced that it has signed an agreement with Novartis to manufacture clinical grade material utilising Oxford BioMedica’s LentiVector® gene delivery technology. Under the terms of the agreement, Oxford BioMedica will also provide certain process development services ... more
The Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute and Evotec AG (EVT) announced a research collaboration aimed at discovering and commercialising novel cancer treatments based on epigenetic drug mechanisms. The goal of the collaboration is to validate emerging ... more
For three days, high-quality laboratory equipment and the latest analysis devices were the focus of the third analytica Vietnam in Ho Chi Minh City. 114 exhibitors from ten countries presented their exhibits to more than 3,400 trade visitors. The content in the program of related events, wh ... more
Using Laser Technology, Aleksandr Ovsianikov from the Vienna University of Technology wants to create microstructures with embedded living cells. This project will be funded by an ERC Starting Grant. The behavior of cells strongly depends on their environment. If they are to be researched a ... more
SYGNIS Pharma AG has been granted the European and US patent for a new basic technology for the detection of protein-protein interactions, a screening platform for the development of novel drugs. Protein-protein interactions falls within the scope of proteomics, a field that is growing in ... more
The first details of the planned reorganisation of the European Medicines Agency (EMA) have been announced. Rooted firmly in the Agency’s overall public and animal health mission, the changes reflect a renewed focus on three key elements: how to better support the scientific work of the EMA ... more
The European Medicines Agency (EMA) has been ordered by the General Court of the European Union not to provide documents as part of two access-to-documents requests until a final ruling is given by the Court. These interim rulings were made as part of court cases brought by two pharmaceutic ... more
Following the recent recommendation by the Pharmacovigilance Risk Assessment Committee (PRAC), the Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) has endorsed by majority the PRAC recommendation to suspend the marketing authorisations of tetrazepam-co ... more
Merck Serono announced that based on its recent analysis of the human growth hormones (HGH) market, Frost & Sullivan recognises Merck Serono with the 2013 Europe Product Differentiation Excellence Award. “Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool. ... more
The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and wil ... more
The European market for interventional radiology and cardiology is heading towards maturity, especially in Western Europe. Although the economic slowdown and fewer orders had a negative impact on revenues in 2012, it is expected that expanding applications of interventional systems and the ... more
The first details of the planned reorganisation of the European Medicines Agency (EMA) have been announced. Rooted firmly in the Agency’s overall public and animal health mission, the changes reflect a renewed focus on three key elements: how to better support the scientific work of the EMA ... more
Following the recent recommendation by the Pharmacovigilance Risk Assessment Committee (PRAC), the Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) has endorsed by majority the PRAC recommendation to suspend the marketing authorisations of tetrazepam-co ... more
The European Medicines Agency has published its 2012 annual report. The report highlights the main trends recently observed in the Agency’s activities. For the past few years, the Agency has received a stable number of initial marketing authorisation applications (MAAs) for human medicines, ... more
Merck Serono announced that based on its recent analysis of the human growth hormones (HGH) market, Frost & Sullivan recognises Merck Serono with the 2013 Europe Product Differentiation Excellence Award. “Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool. ... more
Analytik Jena AG has established a new subsidiary, Analytik Jena Far East (Thailand) Ltd., giving it a presence in the Southeast Asian market. Analytik Jena AG is using this new company to bolster its activities in the Southeast Asian market, increase its regional service for the sales part ... more
Eurofins MWG Operon has launched a new prepaid solution for premixed samples in tubes: SmartSeq Kit. Pooling together purified DNA with the appropriate sequencing primer before sending samples off is a common practice by researchers worldwide. The problem that most researchers face is secur ... more
The Alexander von Humboldt Foundation and the Bayer Science & Education Foundation will soon be awarding joint research fellowships. Until 2018, the Bayer Foundation will be making around three million EUR available to fund approximately ten Humboldt-Bayer Research Fellowships annually. The ... more
Merck announced today that it has signed an agreement with employee representatives on an efficiency plan for the company’s operations in Germany. The efficiency measures are part of the company’s "Fit for 2018" business transformation program spanning all businesses and regions in order to ... more
The Great Place to Work® Institute named Abbott one of the Best Multinational Workplaces in Europe at its European Awards event in Berlin. The company was specifically honored for workplace leadership in Belgium, Denmark, Ireland, Norway and Portugal. This is the third consecutive year that ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
